Literature DB >> 30461128

Incidence of and risk factors for development of oral mucositis in outpatients undergoing cancer chemotherapy.

Seher Çakmak1, Nesrin Nural1.   

Abstract

AIM: The aims of the study are to determine the incidence of oral mucositis, the stage of the condition, risk factors, and other oral complications in patients receiving outpatient chemotherapy and to evaluate the factors that have an impact on these.
METHODS: The study included 147 patients undergoing outpatient cancer chemotherapy at the Chemotherapy Unit of a University Hospital between February and April 2015. We used a questionnaire and the World Health Organization "Mucositis Grading Scale". Chi-squared tests were used to determine the relationships between factors, and multiple logistic regression analysis was employed to explore predictive factors.
RESULTS: The frequency of oral mucositis was 51.7%. The most common oral problems were mouth dryness (55.1%), a reduced/changed sense of taste (52.4%), and a lack of appetite (47.6%). Logistic regression analysis showed that the risk factors for oral mucositis were advanced age, a lack of appetite, and the duration of chemotherapy.
CONCLUSIONS: As a result, half of all patients undergoing outpatient cancer chemotherapy developed oral mucositis. Patients are unable to adequately prevent oral mucositis and carry out oral care. It is recommended that more studies be conducted in outpatient units to evaluate predictive factors for oral mucositis.
© 2018 John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  cancer; chemotherapy; nursing; oral mucositis; outpatients

Mesh:

Substances:

Year:  2018        PMID: 30461128     DOI: 10.1111/ijn.12710

Source DB:  PubMed          Journal:  Int J Nurs Pract        ISSN: 1322-7114            Impact factor:   2.066


  7 in total

Review 1.  Symptom Clusters in Head and Neck Cancer: A Systematic Review and Conceptual Model.

Authors:  Asha Mathew; Amit Jiwan Tirkey; Hongjin Li; Alana Steffen; Mark B Lockwood; Crystal L Patil; Ardith Z Doorenbos
Journal:  Semin Oncol Nurs       Date:  2021-09-03       Impact factor: 3.527

2.  Risk factors for oral mucositis during chemotherapy treatment for solid tumors: a retrospective STROBE-guided study.

Authors:  J-O Martins; M-M Borges; C-E Malta; A-C Carlos; A-A Crispim; J-F Moura; I-J Fernandes-Lima; P-G Silva
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2022-07-01

Review 3.  Anti-inflammatory mouthwashes for the prevention of oral mucositis in cancer therapy: an integrative review and meta-analysis.

Authors:  Clifton P Thornton; Mengchi Li; Chakra Budhathoki; Chao Hsing Yeh; Kathy Ruble
Journal:  Support Care Cancer       Date:  2022-04-29       Impact factor: 3.359

4.  Experiences of patients who developed oral mucositis during solid neoplasms treatment: a Ugandan qualitative study.

Authors:  Adriane Kamulegeya; Damalie Nakanjako; Jackson Orem; Harriet Mayanja-Kizza
Journal:  J Patient Rep Outcomes       Date:  2021-03-06

Review 5.  Oral Immune-Related Adverse Events - Current Concepts and their Management.

Authors:  Mohamed Faizal Asan; Renita Lorina Castelino; Subhas G Babu; Kumuda Rao; Vaibhav Pandita
Journal:  Asia Pac J Oncol Nurs       Date:  2021-10-04

6.  Nigella sativa Oil Mouth Rinse Improves Chemotherapy-Induced Oral Mucositis in Patients with Acute Myeloid Leukemia.

Authors:  Saad Abdulrahman Hussain; Hazha Abdulah Mohammed Ameen; Mohammed Omer Mohammed; Khadija Muhamed Ahmed; Rebaz Hama-Gareb Ali; Banaz Mubarak Safar; Kamal Ahmed Saeed
Journal:  Biomed Res Int       Date:  2019-10-30       Impact factor: 3.411

7.  Professional oral care in end-of-life patients with advanced cancers in a hospice ward: improvement of oral conditions.

Authors:  Ting-Ying Wu; Hsiu-Yueh Liu; Chien-Yi Wu; Hung-Cheng Chen; Shun-Te Huang; Ping-Ho Chen
Journal:  BMC Palliat Care       Date:  2020-11-27       Impact factor: 3.234

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.